Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) moved its Annual General Meeting to September 3 after the September 2 session was adjourned for lack of quorum. The reconvened meeting matters to investors as the stated next step in the company’s Shareholder proceedings at the offices of Meitar Law Offices in Ramat Gan.
Key Highlights
- The September 2 shareholder meeting was adjourned because a quorum was not present.
- The meeting is scheduled to reconvene on September 3 at 4:00 p.m. Israel time.
- The reconvened meeting is scheduled at Meitar | Law Offices in Ramat Gan, Israel.
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) is scheduled to reconvene its annual general meeting of shareholders on September 3 after the September 2 session was adjourned for lack of quorum. The reconvened meeting is scheduled for the same time and place, at the offices of Meitar | Law Offices in Ramat Gan, Israel, the legal counsel’s location.
Shareholder Meeting Moves After Quorum Shortfall
The annual meeting’s September 2 session was adjourned for one day because the meeting lacked a quorum. The reconvened gathering was scheduled for the same time and location specified for the continuation of the meeting. Allen Baharaff, Galmed’s president and chief executive officer, signed on behalf of the company on September 2. The report was signed under the requirements of the Securities Exchange Act of 1934.
September 3 Reconvened Meeting Date
The one-day adjournment moved the annual meeting proceedings to September 3. The reconvened meeting was scheduled as the continuation of the shareholder gathering after the initial session lacked a quorum. The filing identifies the same Ramat Gan offices as the location for the meeting. The filing states that the meeting will be reconvened at that location.
FAQs
Q: Why was Galmed Pharmaceuticals’ annual general meeting adjourned?
A: Galmed Pharmaceuticals’ annual general meeting was adjourned on September 2 because the meeting lacked a quorum. The shareholder meeting was scheduled to reconvene on September 3.
Q: When did Galmed’s shareholder meeting reconvene?
A: Galmed Pharmaceuticals’ annual shareholder meeting was scheduled to reconvene on September 3. The gathering was scheduled to continue at the offices of Meitar | Law Offices in Ramat Gan, Israel.
Q: Where was Galmed Pharmaceuticals’ annual meeting held?
A: The meeting is scheduled to reconvene at the offices of Meitar | Law Offices, Galmed Pharmaceuticals’ legal counsel. Those offices are at 16 Abba Hillel Silver Rd. Ramat Gan, Israel.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.